Recognition and optimal management of schizophrenia and related psychoses

Internal Medicine Journal

Volumn 35, Issue 7, 2005, Pages 413-418

  Singh, Bruce ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atypical antipsychotics; Clinical practice guidelines; Disability; Dopamine; Neuroimaging

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE;

AGRANULOCYTOSIS; AKINESIA; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DISABILITY; DISEASE COURSE; DOPAMINERGIC TRANSMISSION; DROWSINESS; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; GENETIC LINKAGE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HOMELESSNESS; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; LIFESTYLE; LONG TERM CARE; NEUROIMAGING; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOSOCIAL CARE; REVIEW; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; SOCIAL ADAPTATION; THEORY; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; EARLY DIAGNOSIS; HUMANS; PRACTICE GUIDELINES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SOCIOENVIRONMENTAL THERAPY;

EID: 21444439782     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00856.x     Document Type: Review

References (29)

1. Anon. Where next with psychiatric illness (editorial). Nature 1998; 336: 95-6.
2. Murray CJL, Lopez AD. The Global Burden of Disease. Geneva: World Health Organization, Harvard School of Public Health, World Bank; 1996.
3. Hocking B. Reducing mental illness stigma and discrimination - everybody's business. Med J Aust 2003; 178 (Suppl): S47-8.
4. World Health Organization (WHO). International Classification of Diseases, 10th revision. Geneva: WHO; 2003.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington D.C.: American Psychiatric Association; 1994.
6. Kraepelin E. Dementia Praecox and Paraphemia (edited by Robertson GM, translated by Barclay RM, Krieger RE). New York: Huntington; 1971.
7. Hafner H, an der Heiden W. Course and outcome of schizophrenia. In: Hirsh SR, Weinberger DR, eds. Schizophrenia. Oxford: Blackwell Science; 2003: 101-41.
8. Egan MF, Seboyer M, Weinberger DR. Intermediate phenotypes in genetics studies of schizophrenia. In: Hirsh SR, Weinberger DR, eds. Schizophrenia. Oxford: Blackwell Science; 2003: 277-97.
9. Levinson DF. Molecular genetics of schizophrenia: a review of the recent literature. Curr Opin Psychiatry 2003; 16: 157-70.
10. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York: I.U.P; 1950.
11. Johnstone EC, Crow TJ, Firth CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924-6.
12. Weinberger DR, Marencos S. Schizophrenia as a neurodevelopment disorder. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford: Blackwell Science; 1995: 293-323.
13. Kapur S, Lecrubier Y. Dopamine in the Pathophysiology and Treatment of Schizophrenia. London: Martin Dunitz; 2003.
14. Murray RM, Jones PD, Susser E, Van Os J, Cannon M. The Epidemiology of Schizophrenia. New York: Cambridge University Press; 2003.
15. Tamminga CA. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 1998; 12: 21-36.
16. Kapur S, Sridhar N, Remington G. The newer antipsychotics: underlying mechanisms and the new clinical realities. Curr Opin Psychiatry 2004; 17: 115-21.
17. Niznikiewicz M, Kubicki M, Shenton ME. Recent structural and functional imaging findings in schizophrenia. Curr Opin Psychiatry 2003; 16: 123-47.
18. Lambert TJR, Castle DJ. Pharmacological approaches to the management of schizophrenia. Med J Aust 2003; 178 (Suppl) : S57-61.
19. McGorry PD. The recognition and optimal management of early psychosis. An evidence-based reform. World Psychiatry 2002; 1: 76-83.
20. Herz MI, Marder SR. Schizophrenia, Comprehensive Treatment and Management. Philadelphia: Lippincott Williams & Wilkins; 2002.
21. Edwards J, McGorry PD. Implementing Early Intervention in Psychosis. A Guide to Establishing Early Psychosis Services. London: Martin Dunitz; 2002.
22. Yung A, Phillips L, McGorry P. Treating Schizophrenia in the Prodromal Phase. London: Taylor & Francis; 2004.
23. Zipursky RB, Schulz SC. The Early Stages of Schizophrenia. London: American Psychiatric Press; 2002.
24. Castle D, Pantelis C. Comprehensive care for people with schizophrenia living in the community. Med J Aust 2003; 178: S45-6x.
25. Pharoah FM, Mari JJ, Steiner DR. Family intervention for schizophrenia. Cochrane Database Syst Rev 2000; 2: CD000088.
26. Hirsch SR, Weinberger DR. Schizophrenia. Oxford/Cambridge, MA, USA: Blackwell Science; 1995.
27. Rowlands P. The NICE schizophrenia guidelines: the challenge of implementation. Adv Psychiatr Treat 2004; 10: 403-12.
28. Lambert TJR, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003; 178 (Suppl): S67-70.
29. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39: 1-30.